The focus of this study was directed to mutations resulting in the loss of MLH1 and p53 proteins, frequently observed in colorectal cancer (CRC) and ranks as the second most prevalent contributor to cancer‐related deaths. Here, TP53 is linked to colorectal carcinoma.